EMK-16874-47392
1 vaccination
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 784 / TX
- Registered
- 2020-12-17
- Relationship
- Self
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
-
2020-12-17
Survey response — days 1–6 daily, dose 1MedDRA: Back pain, Chest discomfort, Dry eye, Dyspnoea, Feeling abnormal, Gastrointestinal disorder, Headache, Hypertension, Tachycardia — Feeling: Poor · Abdominal painFree text: Had some kind of reaction 20-25 min after receiving vaccine. (Dry eyes, headache, strange sensations radiating throughout body, pressure in abdomen and chest, difficulty taking deep breaths, sever back pain tachycardia and severe hypertension (>170/>100 - no hx high BP). Drove to ER believing I was having an anaphylactiod reaction but started to subside by time i reach ER. Drove back to place I recieved shot and waited 30 min while checking BP. Symptoms short lived barring HTN/ST. BP returned to normal 4 hours later. Did not take meds. Did not experience Hypotension. Would like to talk to a medical professional before taking a second shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Had some kind of reaction 20-25 min after receiving vaccine. (Dry eyes, headache, strange sensations radiating throughout body, pressure in abdomen and chest, difficulty taking deep breaths, sever back pain tachycardia and severe hypertension (>170/>100 - no hx high BP). Drove to ER believing I was having an anaphylactiod reaction but started to subside by time i reach ER. Drove back to place I recieved shot and waited 30 min while checking BP. Symptoms short lived barring HTN/ST. BP returned to normal 4 hours later. Did not take meds. Did not experience Hypotension. Would like to talk to a medical professional before taking a second shot.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Back pain | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Dry eye | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Hypertension | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release